HOOKIPA Pharma Inc (HOOK)

Track

Recent insider activity at HOOKIPA Pharma Inc. includes multiple sell transactions by officers and executives, with the most recent occurring on August 19, 2025. Notably, the Chief Executive Officer and another Officer engaged in proposed sales on this date. Prior to this, the EVP and CFO also sold shares in July 2025. Earlier buy transactions by executives were recorded in July and August 2023.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: HOOK Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Peters Malte

Chief Executive Officer

3 sales — total 60,994 USD

Sale 19 Aug 2025

Value US$3,243,451.14 | Price 337.50 | Shares 92,695

Proposed sale 19 Aug 2025

Value US$240,017.71 | Price 202.55 | Shares 21,348

Proposed sale 19 Aug 2025

Value US$20,155.00 | Price 0.80 | Shares 25,172

Peters Malte

Chief Executive Officer

1 sale — total 26,842 USD

Sale 22 Jul 2025

Value US$2,206,732.86 | Price 402.39 | Shares 42,435

Coelho Mary Theresa

EVP and CFO

1 sale — total 12,520 USD

Sale 22 Jul 2025

Value US$12,520.28 | Price 0.92 | Shares 13,609

Kandera Reinhard

Chief Financial Officer

1 purchase — total 5,075 USD

Buy 21 Aug 2023

Value US$5,075.00 | Price 0.73 | Shares 7,000

Kandera Reinhard

Chief Financial Officer

1 purchase — total 5,712 USD

Buy 16 Aug 2023

Value US$5,712.00 | Price 0.71 | Shares 8,000

Aldag Jorn

Chief Executive Officer

1 purchase — total 4,142 USD

Buy 11 Jul 2023

Value US$4,142.00 | Price 0.83 | Shares 5,000

Aldag Jorn

Chief Executive Officer

1 purchase — total 4,050 USD

Buy 7 Jul 2023

Value US$4,050.00 | Price 0.81 | Shares 5,000

Aldag Jorn

Chief Executive Officer

1 purchase — total 4,450 USD

Buy 5 Jul 2023

Value US$4,450.00 | Price 0.89 | Shares 5,000

Aldag Jorn

Chief Executive Officer

1 purchase — total 4,456 USD

Buy 3 Jul 2023

Value US$4,455.50 | Price 0.89 | Shares 5,000

Kandera Reinhard

Chief Financial Officer

1 purchase — total 10,560 USD

Buy 30 Jun 2023

Value US$10,560.00 | Price 0.88 | Shares 12,000

Matushansky Igor

Chief Medical Officer

3 sales — total 37,223 USD

Sale 21 Dec 2021

Value US$5,490.45 | Price 2.49 | Shares 2,205

Sale 21 Dec 2021

Value US$18,525.60 | Price 2.49 | Shares 7,440

Sale 21 Dec 2021

Value US$13,206.96 | Price 2.49 | Shares 5,304

SOFINNOVA CAPITAL VI FCPR

1 sale — total 3,812,386 USD

Sale 21 Apr 2021

Value US$3,812,386.34 | Price 11.60 | Shares 328,620

SOFINNOVA CAPITAL VI FCPR

1 sale — total 374,569 USD

Planned sale 25 Mar 2021

Value US$374,569.19 | Price 13.12 | Shares 28,546

SOFINNOVA CAPITAL VI FCPR

1 sale — total 721,616 USD

Planned sale 24 Mar 2021

Value US$721,615.90 | Price 13.70 | Shares 52,690

SOFINNOVA CAPITAL VI FCPR

1 sale — total 556,476 USD

Planned sale 23 Mar 2021

Value US$556,476.00 | Price 13.91 | Shares 40,000

SOFINNOVA CAPITAL VI FCPR

1 sale — total 589,263 USD

Planned sale 22 Mar 2021

Value US$589,263.02 | Price 14.54 | Shares 40,534

SOFINNOVA CAPITAL VI FCPR

1 sale — total 2,427,739 USD

Planned sale 19 Mar 2021

Value US$2,427,739.28 | Price 14.60 | Shares 166,230

Matushansky Igor

Chief Medical Officer

2 sales — total 328,343 USD

Sale 17 Dec 2020

Value US$193,781.28 | Price 11.76 | Shares 16,478

Sale 17 Dec 2020

Value US$134,561.70 | Price 11.70 | Shares 11,501

Matushansky Igor

Chief Medical Officer

1 sale — total 4,446 USD

Sale 16 Dec 2020

Value US$4,446.00 | Price 11.70 | Shares 380

SOFINNOVA CAPITAL VI FCPR

1 sale — total 3,000 USD

Planned sale 2 Oct 2020

Value US$3,000.00 | Price 10.00 | Shares 300

SOFINNOVA CAPITAL VI FCPR

2 sales — total 524,477 USD

Planned sale 15 Sep 2020

Value US$121,912.73 | Price 13.16 | Shares 9,261

Planned sale 15 Sep 2020

Value US$402,563.80 | Price 12.45 | Shares 32,336

SOFINNOVA CAPITAL VI FCPR

1 sale — total 149,102 USD

Planned sale 20 Jul 2020

Value US$149,101.95 | Price 11.94 | Shares 12,483

SOFINNOVA CAPITAL VI FCPR

2 sales — total 77,255 USD

Planned sale 29 Jun 2020

Value US$38,627.58 | Price 11.78 | Shares 3,280

Planned sale 29 Jun 2020

Value US$38,627.58 | Price 11.78 | Shares 3,280

Matushansky Igor

Chief Medical Officer

1 sale — total 69,992 USD

Sale 29 Jan 2020

Value US$69,992.45 | Price 12.73 | Shares 5,500

Lilja Anders

Sr. VP, Technical Development

2 sales — total 146,533 USD

Sale 23 Jan 2020

Value US$96,931.70 | Price 12.81 | Shares 7,568

Sale 23 Jan 2020

Value US$49,601.31 | Price 12.17 | Shares 4,075

Orlinger Klaus

Sr. VP, Research

1 sale — total 81,592 USD

Sale 21 Jan 2020

Value US$81,591.56 | Price 12.02 | Shares 6,789

Orlinger Klaus

Sr. VP, Research

1 sale — total 19,781 USD

Sale 16 Jan 2020

Value US$19,781.21 | Price 11.56 | Shares 1,711

Orlinger Klaus

Sr. VP, Research

1 sale — total 96,053 USD

Sale 14 Jan 2020

Value US$96,052.55 | Price 11.30 | Shares 8,500

Matushansky Igor

Chief Medical Officer

1 sale — total 103,312 USD

Sale 19 Dec 2019

Value US$103,311.72 | Price 9.93 | Shares 10,404

Matushansky Igor

Chief Medical Officer

1 sale — total 90,379 USD

Sale 17 Dec 2019

Value US$90,379.08 | Price 7.87 | Shares 11,484

Forbion Capital Fund II Cooperatief U.A.

1 purchase — total 749,994 USD

Buy 23 Apr 2019

Value US$749,994.00 | Price 14.00 | Shares 53,571

SOFINNOVA CAPITAL VI FCPR

1 purchase — total 4,999,988 USD

Buy 23 Apr 2019

Value US$4,999,988.00 | Price 14.00 | Shares 357,142

BAKER BROS. ADVISORS LP

Former 10% owner

2 purchases — total 12,499,998 USD

Buy 23 Apr 2019

Value US$11,490,206.00 | Price 14.00 | Shares 820,729

Buy 23 Apr 2019

Value US$1,009,792.00 | Price 14.00 | Shares 72,128

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-10-09	2025-08-19	S Sale	2.4 Peters Malte Chief Executive Officer Executive Director	92,695 +35.7% 337.50 US$3,243,451	92,695 +35.7%	337.50	US$3,243,451
2025-08-27	2025-08-19	PrS Proposed sale	2.4 Peters Malte Officer Officer	21,348 202.55 US$240,018	21,348	202.55	US$240,018
2025-08-27	2025-08-19	PrS Proposed sale	2.4 Peters Malte Officer Officer	24,491 90.81 US$3,102,020	24,491	90.81	US$3,102,020
2025-07-23	2025-07-22	S Sale	2.4 Peters Malte Chief Executive Officer Executive Director	29,176 -26.8% 0.92 US$26,842	29,176 -26.8%	0.92	US$26,842
2025-07-23	2025-07-22	S Sale	3.8 Coelho Mary Theresa EVP and CFO Executive Director	13,609 -19.5% 0.92 US$12,520	13,609 -19.5%	0.92	US$12,520
2023-08-22	2023-08-21	B Purchase	1.0 Kandera Reinhard Chief Financial Officer Executive Director	7,000 +19.4% 0.73 US$5,075	7,000 +19.4%	0.73	US$5,075
2023-08-17	2023-08-16	B Purchase	1.0 Kandera Reinhard Chief Financial Officer Executive Director	8,000 +28.5% 0.71 US$5,712	8,000 +28.5%	0.71	US$5,712
2023-07-11	2023-07-11	B Purchase	0.9 Aldag Jorn Chief Executive Officer Executive Director	5,000 +7.5% 0.83 US$4,142	5,000 +7.5%	0.83	US$4,142
2023-07-11	2023-07-07	B Purchase	0.9 Aldag Jorn Chief Executive Officer Executive Director	5,000 +8.1% 0.81 US$4,050	5,000 +8.1%	0.81	US$4,050
2023-07-07	2023-07-05	B Purchase	0.9 Aldag Jorn Chief Executive Officer Executive Director	5,000 +8.8% 0.89 US$4,450	5,000 +8.8%	0.89	US$4,450
2023-07-05	2023-07-03	B Purchase	0.9 Aldag Jorn Chief Executive Officer Executive Director	5,000 +9.6% 0.89 US$4,456	5,000 +9.6%	0.89	US$4,456
2023-07-03	2023-06-30	B Purchase	1.0 Kandera Reinhard Chief Financial Officer Executive Director	12,000 +74.6% 0.88 US$10,560	12,000 +74.6%	0.88	US$10,560
2022-01-12	2021-12-21	S Sale	2.6 Matushansky Igor Chief Medical Officer Officer	2,205 -2.5% 2.49 US$5,490	2,205 -2.5%	2.49	US$5,490
2022-01-12	2021-12-21	S Sale	2.6 Matushansky Igor Chief Medical Officer Officer	7,440 -8.1% 2.49 US$18,526	7,440 -8.1%	2.49	US$18,526
2022-01-12	2021-12-21	S Sale	2.6 Matushansky Igor Chief Medical Officer Officer	5,304 -6.2% 2.49 US$13,207	5,304 -6.2%	2.49	US$13,207
2021-04-23	2021-04-21	S Sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	328,620 -9.4% 11.60 US$3,812,386	328,620 -9.4%	11.60	US$3,812,386
2021-03-29	2021-03-25	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	28,546 -0.8% 13.12 US$374,569	28,546 -0.8%	13.12	US$374,569
2021-03-26	2021-03-24	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	52,690 -1.4% 13.70 US$721,616	52,690 -1.4%	13.70	US$721,616
2021-03-25	2021-03-23	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	40,000 -1.1% 13.91 US$556,476	40,000 -1.1%	13.91	US$556,476
2021-03-24	2021-03-22	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	40,534 -1.1% 14.54 US$589,263	40,534 -1.1%	14.54	US$589,263
2021-03-23	2021-03-19	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	166,230 -4.3% 14.60 US$2,427,739	166,230 -4.3%	14.60	US$2,427,739
2020-12-18	2020-12-17	S Sale	2.6 Matushansky Igor Chief Medical Officer Officer	16,478 -17.6% 11.76 US$193,781	16,478 -17.6%	11.76	US$193,781
2020-12-18	2020-12-17	S Sale	2.6 Matushansky Igor Chief Medical Officer Officer	11,501 -15.2% 11.70 US$134,562	11,501 -15.2%	11.70	US$134,562
2020-12-18	2020-12-16	S Sale	2.6 Matushansky Igor Chief Medical Officer Officer	380 -0.7% 11.70 US$4,446	380 -0.7%	11.70	US$4,446
2020-10-06	2020-10-02	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	300 -0.0% 10.00 US$3,000	300 -0.0%	10.00	US$3,000
2020-09-17	2020-09-15	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	9,261 -0.2% 13.16 US$121,913	9,261 -0.2%	13.16	US$121,913
2020-09-17	2020-09-15	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	32,336 -0.8% 12.45 US$402,564	32,336 -0.8%	12.45	US$402,564
2020-07-22	2020-07-20	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	12,483 -0.3% 11.94 US$149,102	12,483 -0.3%	11.94	US$149,102
2020-07-22	2020-06-29	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	3,280 -0.1% 11.78 US$38,628	3,280 -0.1%	11.78	US$38,628
2020-07-01	2020-06-29	PlS Planned sale	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	3,280 -0.1% 11.78 US$38,628	3,280 -0.1%	11.78	US$38,628
2020-01-31	2020-01-29	S Sale	2.6 Matushansky Igor Chief Medical Officer	5,500 -9.3% 12.73 US$69,992	5,500 -9.3%	12.73	US$69,992
2020-01-27	2020-01-23	S Sale	3.1 Lilja Anders Sr. VP, Technical Development	7,568 -100.0% 12.81 US$96,932	7,568 -100.0%	12.81	US$96,932
2020-01-27	2020-01-23	S Sale	3.1 Lilja Anders Sr. VP, Technical Development	4,075 -100.0% 12.17 US$49,601	4,075 -100.0%	12.17	US$49,601
2020-01-21	2020-01-21	S Sale	2.9 Orlinger Klaus Sr. VP, Research	6,789 -100.0% 12.02 US$81,592	6,789 -100.0%	12.02	US$81,592
2020-01-21	2020-01-16	S Sale	2.9 Orlinger Klaus Sr. VP, Research	1,711 -100.0% 11.56 US$19,781	1,711 -100.0%	11.56	US$19,781
2020-01-16	2020-01-14	S Sale	2.9 Orlinger Klaus Sr. VP, Research	8,500 -100.0% 11.30 US$96,053	8,500 -100.0%	11.30	US$96,053
2019-12-23	2019-12-19	S Sale	Matushansky Igor Chief Medical Officer Officer	10,404 -15.0% 9.93 US$103,312	10,404 -15.0%	9.93	US$103,312
2019-12-19	2019-12-17	S Sale	Matushansky Igor Chief Medical Officer Officer	11,484 -20.9% 7.87 US$90,379	11,484 -20.9%	7.87	US$90,379
2019-04-25	2019-04-23	B Purchase	0.5 Forbion Capital Fund II Cooperatief U.A. Large shareholder	53,571 +2.2% 14.00 US$749,994	53,571 +2.2%	14.00	US$749,994
2019-04-25	2019-04-23	B Purchase	1.3 SOFINNOVA CAPITAL VI FCPR Large shareholder	357,142 +9.9% 14.00 US$4,999,988	357,142 +9.9%	14.00	US$4,999,988
2019-04-23	2019-04-23	B Purchase	3.9 BAKER BROS. ADVISORS LP Former 10% owner	820,729 +inf% 14.00 US$11,490,206	820,729 +inf%	14.00	US$11,490,206
2019-04-23	2019-04-23	B Purchase	3.9 BAKER BROS. ADVISORS LP Former 10% owner	72,128 +inf% 14.00 US$1,009,792	72,128 +inf%	14.00	US$1,009,792